Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI-Powered Technology Identifies Abnormalities in CT Scans

By HospiMedica International staff writers
Posted on 30 Apr 2018
A new artificial intelligence (AI)-powered technology can accurately identify bleeds, fractures and other critical abnormalities in head CT scans, and can automatically generate abnormality reports. More...
These automated reports are a first-to-market capability in the AI and radiology category, helping radiologists and hospitals prioritize care, make smarter and faster diagnoses and reduce costs.

The new head CT scan technology has been launched by Qure.ai (Mumbai, India), a healthcare AI startup, which focuses on making healthcare affordable and accessible using the power of AI. Its deep neural networks can understand and interpret medical images accurately and enable machines to perform routine diagnostics, thus improving healthcare outcomes and costs. Until now, Qure.ai has delivered AI-powered chest, abdomen and musculoskeletal image interpretation technology. The company has now launched capabilities for head and brain CT scans for the first-time.

Qure.ai trained the new AI using a collection of 313,318 anonymized head CT scans, along with their corresponding clinical reports. Out of these, 21,095 scans were used to validate the AI's algorithms. Finally, the AI was clinically validated on 491 CT scans, with the results compared against a panel of three senior radiologists. The validation study found that Qure.ai's AI to be more than 95% accurate in identifying abnormalities.

The company has also made a dataset of 491 AI-interpreted head CT scans, as well as the corresponding interpretations from the three radiologists, publicly available for download. This dataset is from the Centre for Advanced Research in Imaging, Neurosciences and Genomics, and includes both outpatient and in-patient scans from seven centers.

"Qure.ai's new head CT scan technology rapidly screens scans in under 10 seconds to detect, localize and quantify abnormalities, as well as assess their severity," said Prashant Warier, Co-Founder and CEO, Qure.ai. "This enables patient prioritization and the appropriate clinical intervention."

"We are delivering near-radiologist accurate AI to support radiologists, physicians and healthcare providers," said Sasank Chilamkurthy, AI Scientist, Qure.ai. "Our deep learning algorithms can accurately detect and highlight head CT scan abnormalities, reducing the chances of missing a diagnosis. Our technology can also localize the brain regions affected and quantify the bleed regions in a fully-automated report."

Related Links:
Qure.ai


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.